青少年和年轻成人癌症治疗期间监督下运动干预:FiGHTING F!T随机对照试验研究方案
FiGHTING F!T是一项随机对照交叉试验,计划招募40例近期诊断并即将开始系统治疗的青少年和年轻成人(AYA)原发血液恶性肿瘤或实体瘤患者,随机分配至立即运动干预组或常规照护(延迟运动)组,进行为期10周的监督下结构化渐进式运动项目,以评估其对癌症治疗相关体能(V02peak)下降的缓解作用。
要点
- AYA癌症患者运动干预证据不足,本试验填补该空白。
- 监督下双周运动项目结合有氧和抗阻训练。
- 主要评估指标为心肺运动试验测得的V02peak。
核心结论
- FiGHTING F!T试验将探究监督下运动项目对接受癌症治疗的AYA患者的潜在获益。
- 该试验有助于为癌症治疗期间整合运动提供证据,特别是在报道不足的AYA人群中。
研究设计与样本
- 随机对照交叉试验,计划招募40例近期诊断并即将开始系统治疗(±2周)的原发血液恶性肿瘤或实体瘤AYA患者。
- 随机分配至立即运动干预组(0-10周)或常规照护/延迟运动组(10-20周),两组均接受监督下运动干预10周。
- 双周定制运动项目结合有氧和抗阻运动,由认证运动生理学家监督。
- 在0、10和20周完成评估,包括心肺运动试验、1次重复最大力量测量、身体功能和自报生活质量;每周记录患者报告的治疗相关毒性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-quality evidence supports the integration of exercise to mitigate treatment-related side effects in a wide range of paediatric and adult cancer cohorts. However, the implementation of exercise in adolescent and young adult (AYA) cancer patients is yet to be explored in depth. FiGHTINGF!T is a randomised controlled cross over trial designed to determine if a supervised, structured, and progressive exercise programme can reduce the decline in physical fitness (V02peak) associated with cancer treatment in AYAs from diagnosis. METHODS/DESIGN: A total of 40 AYAs recently diagnosed and due to commence systemic treatment (± 2 weeks) for a primary haematological malignancy or solid tumour will be recruited and randomised to either an immediate exercise intervention or usual care (delayed exercise) for 10 weeks. This randomised controlled crossover trial will see both groups engage in a supervised exercise intervention from either diagnosis (baseline assessment) for 10 weeks (0-10 weeks) or following an interim assessment to 20 weeks (10-20 weeks). The bi-weekly tailored exercise programme will combine aerobic and resistance exercises and be supervised by an Accredited Exercise Physiologist. Participants will complete a range of assessments at 0, 10, and 20 weeks including cardiopulmonary exercise tests, 1 repetition maximum strength measures, physical functioning, and self-reported quality of life measurements. Patient-reported treatment-related toxicities will be recorded on a weekly basis. DISCUSSION: The FiGHTINGF!T trial will provide insight into the potential benefits of a supervised exercise programme in AYAs undergoing cancer treatment. This trial will contribute to the evidence supporting the necessary integration of exercise during cancer treatment, specifically in the under-reported AYA cohort. TRIAL REGISTRATION: This trial was registered retrospectively with the Australia New Zealand Clinical Trial registry ( ACTRN12620000663954 ). Registered on 10 June 2020.
引用
- Munsie C, Ebert J, Collins J, et al. A supervised exercise intervention during cancer treatment for adolescents and young adults-FiGHTING F!T: study protocol of a randomised controlled trial. Trials. 2021. PMID: 34602065. doi:10.1186/s13063-021-05616-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。